BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2004
View Archived Issues
Efficacy of stampidine shown in vitro against resistant HIV-1 isolates
Read More
Antiinflammatory action of ethyl pyruvate mediated in part via GSH depletion
Read More
Good safety profile reported for BBR-3576 in patients with advanced solid tumors
Read More
Full clinical results reported for eculizumab in paroxysmal nocturnal hemoglobinuria
Read More
2003 record year at Serono
Read More
New Viracept formulation recommended for approval in Europe
Read More
Iseganan program selected for CMA Pilot 2 program
Read More
Medtronic receives conditional approval to commence ENDEAVOR III trial
Read More
University of Pennsylvania studies chromium picolinate for metabolic syndrome
Read More
Vivus to develop Testosterone MDTS, Estradiol MDTS for U.S.
Read More
Salix updates Q4 and year-end 2003 developments
Read More
Seattle Genetics highlights 2003 development progress
Read More
Two series of factor VIIa inhibitors presented by BMS researchers
Read More
Novel renin inhibitors in early development at Actelion
Read More
Spanish researchers describe new muscarinic M3 antagonists and their use
Read More
Novel oxytocin antagonists and their use as tocolytics reported by ARS team
Read More
Indian scientists claim new anthramycin-based antitumor agents
Read More
Allergan patent covers antitumor agents for breast and prostate cancer therapy
Read More
New COX inhibitors identified by Boehringer Ingelheim scientists
Read More
Two novel series of antibacterial agents prepared and tested at GSK
Read More
Elan completes recovery plan
Read More
Erbitux receives FDA approval
Read More
Aventis selects target in GPC Biotech osteoarthritis alliance
Read More
FDA approval for benazepril hydrochloride
Read More
Prevnar allocation program continues
Read More
Concerta approved in Australia
Read More
Symbollon plans pivotal IoGen trial for fibrocystic breast disease
Read More
Altana seeks European approval for Daxas
Read More
Dermatrends demonstrates effective transdermal delivery of testosterone
Read More
Neurologix completes merger with Change Technology Partners
Read More
E-5564 reported safe and effective in a human model of clinical sepsis
Read More